Atmus Filtration Technologies Inc.’s stock soared 14% Friday in its trading debut, after the Cummins Inc. spinoff priced its initial public offering in the middle of its proposed price range.

The Nashville, Tenn.-based company sold 14.1 million shares priced at $19.50 each to raise $275 million. With 83.3 million shares to be outstanding after the deal, the company’s valuation is $1.6 billion.

The stock

is trading on the New York Stock Exchange under the ticker ATMU. Goldman Sachs and JPMorgan Chase were lead book-running managers on the deal, with 10 other banks acting as co-managers.

Although the company is issuing primary shares, Atmus will not receive any of the IPO proceeds; all of the proceeds will go to debt-for-equity exchange parties, namely underwriters Goldman Sachs and JPMorgan, and will indirectly pay down parent Cummins’

debt, according to the filing documents.

Atmus makes products for on-highway commercial vehicles and off-highway agriculture, construction, mining and power-generation vehicles and equipment, mostly under the Fleetguard brand. The company had pro forma net income of $34.9 million in the first quarter on sales of $418.6 million.

About 16% of its 2022 sales went to original-equipment manufacturers, where its filters are used for new vehicles and equipment, and about 84% were aftermarket sales.

The company was created by Cummins, a maker of diesel and natural-gas engines, in 1958.

The IPO comes in a thin year for deals. There have been just 44 IPOs this year to raise $7.3 billion in proceeds, according to Renaissance Capital, a provider of IPO exchange-traded funds and institutional research.

That’s up 29.4% from the same period in 2022, when deal flow slowed to its lightest in decades.

“Deal flow started at a decent pace but failed to pick back up after the February lull, as hawkish signals from the Fed, renewed recession fears, and turmoil within the banking industry caused a spike in volatility,” Renaissance wrote in April commentary.

The biggest deal of the year to date was that of Kenvue Inc.
a spinoff from Johnson & Johnson
which is parent to a number of household brands, including Tylenol, Band-Aid, Listerine and Benadryl.

For more, see: Kenvue stock cheered in Wall Street debut, as Tylenol and Band-Aid brand parent is valued at $48 billion

Kenvue raised $3.8 billion after pricing above range and achieving a valuation of $41 billion.

The Renaissance IPO ETF

has gained 18% in the year to date, while the S&P 500

has gained 9%.

Source link

You May Also Like

Daily horoscope for November 14, 2022

We’re likely feeling buffeted by forces bigger than ourselves. The vulnerable Moon…

Southwest Airlines flight cancellations continue to snowball

DALLAS — Travelers who counted on Southwest Airlines to get them home…

AP source: American troops are evacuating US embassy staff from Sudan as fighting persists in the capital Khartoum

AP source: American troops are evacuating US embassy staff from Sudan as…

Iranian climber Elnaz Rekabi returns to Tehran after competing overseas without hijab

LONDON — Iranian sport climber Elnaz Rekabi returned to Tehran early Wednesday…